<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38248722</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4426</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>22</Day></PubDate></JournalIssue><Title>Journal of personalized medicine</Title><ISOAbbreviation>J Pers Med</ISOAbbreviation></Journal><ArticleTitle>Assessment of Some Risk Factors and Biological Predictors in the Post COVID-19 Syndrome in Asthmatic Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">21</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jpm14010021</ELocationID><Abstract><AbstractText>Long COVID-19 or post-COVID infection (PCI) refers to the prolongation of symptoms in people who have been infected with the SARS-CoV-2 virus. Some meta-analysis studies have shown that patients with comorbidities, such as diabetes, obesity or hypertension, have severe complications after infection with the SARS-CoV-2 virus. The presence of chronic respiratory diseases such as bronchial asthma, COPD, pulmonary hypertension or cystic fibrosis increases the risk of developing severe forms of the COVID-19 disease. The risk of developing the severe form of COVID-19 was observed in patients with bronchial asthma being treated with corticosteroids, but also in those hospitalized with severe asthma. The biological variables determined in patients with PCI infection showed changes, especially in the hematological parameters, but also in some inflammatory markers. The aim of this study was to investigate some biological predictors in post-COVID-19 infection in patients with asthma and various comorbidities. In the case of patients diagnosed with moderate and severe forms of COVID-19, the variation in biological tests has shown high concentrations for serum glucose, lactate dehydrogenase and C-reactive protein. Additionally, the calculation of the relative risk (RR) based on the associated comorbidities in patients with PCI points to higher values for patients with asthma, hypertension, diabetes and obesity (RR moderate/severe form = 0.98/1.52), compared to patients with PCI and asthma (RR moderate/severe form = 0.36/0.63). Based on the statistical results, it can be concluded that the alanine aminotransferase (ALT) activity (<i>p</i> = 0.006) and the age of patients (<i>p</i> = 0.001) are the variables that contribute the most to the separation of the four classes of comorbidities considered.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Melinte</LastName><ForeName>Oana Elena</ForeName><Initials>OE</Initials><AffiliationInfo><Affiliation>Discipline of Pneumology, III-rd Medical Department, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robu Popa</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Discipline of Pneumology, III-rd Medical Department, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dobrin</LastName><ForeName>Mona Elisabeta</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Clinical Hospital of Pulmonary Diseases, 700116 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cernomaz</LastName><ForeName>Andrei Tudor</ForeName><Initials>AT</Initials><Identifier Source="ORCID">0000-0002-5690-8638</Identifier><AffiliationInfo><Affiliation>Discipline of Pneumology, III-rd Medical Department, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grigorescu</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Discipline of the Thoracic Surgery, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nemes</LastName><ForeName>Alexandra Floriana</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Doctoral School, Faculty of Medicine, "Titu Maiorescu" University, 031593 Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gradinaru</LastName><ForeName>Adina Catinca</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Discipline of Pharmaceutical Botany, Faculty of Pharmacy, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vicol</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Discipline of Pneumology, III-rd Medical Department, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Todea</LastName><ForeName>Doina Adina</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0003-1306-2350</Identifier><AffiliationInfo><Affiliation>Discipline of Pneumology, Department of Medical Sciences, Faculty of Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vulturar</LastName><ForeName>Damiana Maria</ForeName><Initials>DM</Initials><Identifier Source="ORCID">0000-0002-6805-1619</Identifier><AffiliationInfo><Affiliation>Discipline of Pneumology, Department of Medical Sciences, Faculty of Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cioroiu</LastName><ForeName>Ionel Bogdan</ForeName><Initials>IB</Initials><Identifier Source="ORCID">0000-0001-6136-5204</Identifier><AffiliationInfo><Affiliation>Romanian Academy-Iasi Branch, Research Center for Oenology, 700490 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trofor</LastName><ForeName>Antigona Carmen</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0003-3252-7715</Identifier><AffiliationInfo><Affiliation>Discipline of Pneumology, III-rd Medical Department, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Pers Med</MedlineTA><NlmUniqueID>101602269</NlmUniqueID><ISSNLinking>2075-4426</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">asthma</Keyword><Keyword MajorTopicYN="N">biological variables</Keyword><Keyword MajorTopicYN="N">comorbidities</Keyword><Keyword MajorTopicYN="N">post-COVID-19 syndrome</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>4</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38248722</ArticleId><ArticleId IdType="pmc">PMC10820086</ArticleId><ArticleId IdType="doi">10.3390/jpm14010021</ArticleId><ArticleId IdType="pii">jpm14010021</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Greenhalgh T., Knight M., A&#x2019;court C., Buxton M., Husain L. Management of post-acute COVID-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg P., Arora U., Kumar A., Wig N. The &#x201c;post-COVID&#x201d; syndrome: How deep is the damage? J. Med. Virol. 2021;93:673&#x2013;674. doi: 10.1002/jmv.26465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26465</ArticleId><ArticleId IdType="pmc">PMC7461449</ArticleId><ArticleId IdType="pubmed">32852801</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco A.L., Pacheco R.L., Bagattini &#xc2;.M., Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review. Int. J. Clin. Pract. 2021;75:e14357. doi: 10.1111/ijcp.14357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14357</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Marzook H., Ahmad F. Comorbidities and clinical complications associated with SARS-CoV-2 infection: An overview. Clin. Exp. Med. 2023;23:313&#x2013;331. doi: 10.1007/s10238-022-00821-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-022-00821-4</ArticleId><ArticleId IdType="pmc">PMC8972750</ArticleId><ArticleId IdType="pubmed">35362771</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva Andrade B., Siqueira S., de Assis Soares W.R., de Souza Rangel F., Santos N.O., dos Santos Freitas A., Ribeiro da Silveira P., Tiwari S., Alzahrani K.J., G&#xf3;es-Neto A., et al. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses. 2021;13:700. doi: 10.3390/v13040700.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13040700</ArticleId><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference><Reference><Citation>Achkar M., Jamal O., Chaaban T. Post-COVID lung disease(s) Ann. Thorac. Med. 2022;17:137&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9374125</ArticleId><ArticleId IdType="pubmed">35968401</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Initiative for Asthma GINA Global Strategy for Asthma Management and Prevention Global Initiative for Asthma (GINA) What&#x2019;s New in GINA. 2021.  [(accessed on 21 November 2022)].  Available online:  www.ginasthma.org.</Citation></Reference><Reference><Citation>Lee S.C., Son K.J., Han C.H., Jung J.Y., Park S.C. Impact of comorbid asthma on severity of coronavirus disease (COVID-19) Sci. Rep. 2020;10:21805. doi: 10.1038/s41598-020-77791-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-77791-8</ArticleId><ArticleId IdType="pmc">PMC7733453</ArticleId><ArticleId IdType="pubmed">33311519</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassoro D.D., Mujwahuzi L., Mwakyula I.H., Possi M.K., Lyantagaye S.L. Asthma and COVID-19: Emphasis on Adequate Asthma Control. Can. Respir. J. 2021;2021:9621572. doi: 10.1155/2021/9621572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/9621572</ArticleId><ArticleId IdType="pmc">PMC8397565</ArticleId><ArticleId IdType="pubmed">34457096</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Y.-J., Liu S.-H., Manachevakul S., Lee T.-A., Kuo C.-T., Bello D. Biomarkers in long COVID-19: A systematic review. Front. Med. 2023;10:1085988. doi: 10.3389/fmed.2023.1085988.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1085988</ArticleId><ArticleId IdType="pmc">PMC9895110</ArticleId><ArticleId IdType="pubmed">36744129</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P., Patel U., Mehta D., Patel N., Kelkar R., Akrmah M., Gabrilove J.L., Sacks H. Biomarkers and outcomes of COVID-19 hospitalisations: Systematic review and meta-analysis. BMJ Evid. Based Med. 2021;26:107&#x2013;108. doi: 10.1136/bmjebm-2020-111536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjebm-2020-111536</ArticleId><ArticleId IdType="pmc">PMC7493072</ArticleId><ArticleId IdType="pubmed">32934000</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Tjendra Y., Al Mana A.F., Espejo A.P., Akgun Y., Millan N.C., Gomez-Fernandez C., Cray C. Predicting Disease Severity and Outcome in COVID-19 Patients: A Review of Multiple Biomarkers. Arch. Pathol. Lab. Med. 2020;144:1465&#x2013;1474. doi: 10.5858/arpa.2020-0471-SA.</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/arpa.2020-0471-SA</ArticleId><ArticleId IdType="pubmed">32818235</ArticleId></ArticleIdList></Reference><Reference><Citation>Delshad M., Tavakolinia N., Pourbagheri-Sigaroodi A., Safaroghli-Azar A., Bagheri N., Bashash D. The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19. Int. Immunopharmacol. 2021;95:107586. doi: 10.1016/j.intimp.2021.107586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107586</ArticleId><ArticleId IdType="pmc">PMC7969831</ArticleId><ArticleId IdType="pubmed">33765611</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q., Meng M., Kumar R., Wu Y., Huang J., Deng Y., Weng Z., Yang L. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis. Int. J. Infect. Dis. 2020;96:131&#x2013;135. doi: 10.1016/j.ijid.2020.04.086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.04.086</ArticleId><ArticleId IdType="pmc">PMC7196544</ArticleId><ArticleId IdType="pubmed">32376308</ArticleId></ArticleIdList></Reference><Reference><Citation> [(accessed on 15 July 2023)].  Available online:  https://emeraldmed.ro/covid-19-si-boala-trombotica-si-trombo-embolica/</Citation></Reference><Reference><Citation>Tsampasian V., Elghazaly H., Chattopadhyay R., Debski M., Naing T.K.P., Garg P., Clark A., Ntatsaki E., Vassiliou V.S. Risk Factors Associated With Post&#x2212;COVID-19 Condition: A Systematic Review and Meta-analysis. JAMA Intern. Med. 2023;183:566&#x2013;580. doi: 10.1001/jamainternmed.2023.0750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasileva D., Badawi A. C-reactive protein as a biomarker of severe H1N1 influenza. Inflamm. Res. 2019;68:39&#x2013;46. doi: 10.1007/s00011-018-1188-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-018-1188-x</ArticleId><ArticleId IdType="pmc">PMC6314979</ArticleId><ArticleId IdType="pubmed">30288556</ArticleId></ArticleIdList></Reference><Reference><Citation>Serin I., Sari N.D., Dogu M.H., Acikel S.D., Babur G., Ulusoy A., Onar M.I., Gokce E.C., Altunok O., Yaylaci Mert F., et al. A new parameter in COVID-19 pandemic: Initial lactate dehydrogenase (LDH)/Lymphocyte ratio for diagnosis and mortality. J. Infect. Public Health. 2020;13:1664&#x2013;1670. doi: 10.1016/j.jiph.2020.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2020.09.009</ArticleId><ArticleId IdType="pmc">PMC7526632</ArticleId><ArticleId IdType="pubmed">33071210</ArticleId></ArticleIdList></Reference><Reference><Citation>Crisan-Dabija R., Covic A., Brinza C., Popa I.V., Burlacu A. Involvement of KL-6 Biomarker in Interstitial Lung Disease Induced by SARS-CoV-2 Infection: A Systematic Review. Appl. Sci. 2021;11:3482. doi: 10.3390/app11083482.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/app11083482</ArticleId></ArticleIdList></Reference><Reference><Citation>Tordjman M., Mekki A., Mali R.D., Monnier H., Neveu S., Chassagnon G., Mihoubi F., Carlier N., Marey J., Fournier L., et al. Determining extent of COVID-19 pneumonia on CT based on biological variables. Respir. Med. 2020;175:106206. doi: 10.1016/j.rmed.2020.106206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2020.106206</ArticleId><ArticleId IdType="pmc">PMC7644196</ArticleId><ArticleId IdType="pubmed">33166904</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C., Zhou L., Hu Z., Zhang S., Yang S., Tao Y., Xie C., Ma K., Shang K., Wang W., et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin. Infect. Dis. 2020;71:762&#x2013;768. doi: 10.1093/cid/ciaa248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa248</ArticleId><ArticleId IdType="pmc">PMC7108125</ArticleId><ArticleId IdType="pubmed">32161940</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y., Yang Y., Wang F., Ren H., Zhang S., Shi X., Yu X., Dong K. Clinical characteristics and outcomes of patients with severe COVID-19 with diabetes. BMJ Open Diabetes Res. Care. 2020;8:e001343. doi: 10.1136/bmjdrc-2020-001343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjdrc-2020-001343</ArticleId><ArticleId IdType="pmc">PMC7222577</ArticleId><ArticleId IdType="pubmed">32345579</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C.C., Liu Y.H., Wang C.Y., Wang Y.H., Hsueh S.C., Yen M.Y., Ko W.C., Hsueh P.R. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. J. Microbiol. Immunol. Infect. 2020;53:404&#x2013;412. doi: 10.1016/j.jmii.2020.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2020.02.012</ArticleId><ArticleId IdType="pmc">PMC7128959</ArticleId><ArticleId IdType="pubmed">32173241</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali A.H.M., Mohamed S.O.O., Elkhidir I.H.E., Elbathani M.E.H., Ibrahim A.A.H., Elhassan A.B.E., Tawer Salman M.S., Elhassan M.A., Elnil M., Hassan Abuzied A.I. The Association of Lymphocyte count, CRP, D-Dimer, and LDH with Severe Coronavirus Disease 2019 (COVID-19): A Meta-Analysis. Sudan J. Med. Sci. 2020;15:9&#x2013;19. doi: 10.18502/sjms.v15i5.7146.</Citation><ArticleIdList><ArticleId IdType="doi">10.18502/sjms.v15i5.7146</ArticleId></ArticleIdList></Reference><Reference><Citation>Usul E., &#x15e;an &#x130;., Bekg&#xf6;z B., &#x15e;ahin A. Role of hematological parameters in COVID-19 patients in the emergency room. Biomark. Med. 2020;14:1207&#x2013;1215. doi: 10.2217/bmm-2020-0317.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/bmm-2020-0317</ArticleId><ArticleId IdType="pmc">PMC7372996</ArticleId><ArticleId IdType="pubmed">32692248</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawy A.M., Sadek M.S., Mogahed M.M., Khamis A., Allam A.H. Relationship between bronchial asthma and COVID-19 infection in adults: Clinical and laboratory assessment. Egypt J. Bronchol. 2023;17:12. doi: 10.1186/s43168-023-00183-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43168-023-00183-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanannejad Z., Alyasin S., Esmaeilzadeh H., Nabavizadeh H., Amin R. Asthma and COVID-19 pandemic: Focus on the eosinophil count and ACE2 expression. Eur. Ann. Allergy Clin. Immunol. 2022;54:284&#x2013;289. doi: 10.23822/EurAnnACI.1764-1489.233.</Citation><ArticleIdList><ArticleId IdType="doi">10.23822/EurAnnACI.1764-1489.233</ArticleId><ArticleId IdType="pubmed">34503323</ArticleId></ArticleIdList></Reference><Reference><Citation>Prompetchara E., Ketloy C., Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac. J. Allergy Immunol. 2020;38:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">32105090</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaszuba M., Madej N., Pilinski R., Sliwka A. Post-COVID-19 Symptoms in Adults with Asthma&#x2014;Systematic Review. Biomedicines. 2023;11:2268. doi: 10.3390/biomedicines11082268.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11082268</ArticleId><ArticleId IdType="pmc">PMC10452668</ArticleId><ArticleId IdType="pubmed">37626764</ArticleId></ArticleIdList></Reference><Reference><Citation>Kantri A., Ziati J., Khalis M., Haoudar A., El Aidaoui K., Daoudi Y., Chikhaoui I., El Kettani C. Hematological and biochemical abnormalities associated with severe forms of COVID-19: A retrospective single-center study from Morocco. PLoS ONE. 2021;16:e0246295. doi: 10.1371/journal.pone.0246295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0246295</ArticleId><ArticleId IdType="pmc">PMC7861397</ArticleId><ArticleId IdType="pubmed">33539383</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrin M.E., Rohozneanu O.E., Dabija C., Cernat R.E., Buculei I., Cernat R.I., Popa E., Trofor A. Prospective biochemical and hematological markers to differentiation severe from non-severe COVID-19 disease. Eur. Respir. J. 2021;58:PA3879.</Citation></Reference><Reference><Citation>Fialek B., Pruc M., Smereka J., Jas R., Rahnama-Hezavah M., Denegri A., Szarpak A., Jaguszewski M.J., Peacock F.W., Szarpak L. Diagnostic value of lactate dehydrogenase in COVID-19: A systematic review and meta-analysis. Cardiol. J. 2022;29:751&#x2013;758. doi: 10.5603/CJ.a2022.0056.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/CJ.a2022.0056</ArticleId><ArticleId IdType="pmc">PMC9550334</ArticleId><ArticleId IdType="pubmed">35762075</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta G.S. The Lactate and the Lactate Dehydrogenase in Inflammatory Diseases and Major Risk Factors in COVID-19 Patients. Inflammation. 2022;45:2091&#x2013;2123. doi: 10.1007/s10753-022-01680-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-022-01680-7</ArticleId><ArticleId IdType="pmc">PMC9117991</ArticleId><ArticleId IdType="pubmed">35588340</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#x119;ca T., Wojtowicz K., Guzik P., G&#xf3;ra T. Increased Risk of COVID-19 in Patients with Diabetes Mellitus-Current Challenges in Pathophysiology, Treatment and Prevention. Int. J. Environ. Res. Public. Health. 2022;19:6555. doi: 10.3390/ijerph19116555.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19116555</ArticleId><ArticleId IdType="pmc">PMC9180541</ArticleId><ArticleId IdType="pubmed">35682137</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam M.B., Chowdhury U.N., Nashiry M.A., Moni M.A. Severity of COVID-19 patients with coexistence of asthma and vitamin D deficiency. Inform. Med. Unlocked. 2022;34:101116. doi: 10.1016/j.imu.2022.101116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imu.2022.101116</ArticleId><ArticleId IdType="pmc">PMC9616486</ArticleId><ArticleId IdType="pubmed">36338941</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahangirimehr A., Abdolahi Shahvali E., Rezaeijo S.M., Khalighi A., Honarmandpour A., Honarmandpour F., Labibzadeh M., Bahmanyari N., Heydarheydari S. Machine learning approach for automated predicting of COVID-19 severity based on clinical and paraclinical characteristics: Serum levels of zinc, calcium, and vitamin D. Clin. Nutr. ESPEN. 2022;51:404&#x2013;411. doi: 10.1016/j.clnesp.2022.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnesp.2022.07.011</ArticleId><ArticleId IdType="pmc">PMC9339089</ArticleId><ArticleId IdType="pubmed">36184235</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>